ProPhase Labs, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $11.2M | $434.0K |
| FY2020 | $10.0M | $10.6M | $6.8M |
| FY2021 | $10.0M | $58.6M | $8.4M |
| FY2022 | $0 | $63.6M | $9.1M |
| FY2023 | $2.9M | $49.4M | $1.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $11.2M | $434.0K |
| FY2020 | $10.0M | $10.6M | $6.8M |
| FY2021 | $10.0M | $58.6M | $8.4M |
| FY2022 | $0 | $63.6M | $9.1M |
| FY2023 | $2.9M | $49.4M | $1.6M |